Loading organizations...
Easton Capital operates as a specialized venture capital fund, primarily deploying capital into the healthcare and life sciences sectors. The firm distinguishes itself by offering a blend of financial, strategic, and operational expertise, aiming to support portfolio companies beyond mere investment. This comprehensive approach leverages decades of sector-specific experience from its professional team to guide emerging businesses.
The firm was established in 2000 by John H. Friedman. His foundational insight centered on a classical venture capital philosophy, emphasizing rigorous transaction structuring to optimize potential returns while mitigating risks across diverse economic environments. This perspective led to a focus on companies capable of achieving significant milestones with efficient capital deployment.
Easton Capital partners with entrepreneurs whose ventures offer services or products that can substantially enhance healthcare quality or reduce associated costs. The firm’s vision is to align closely with these businesses, working to maximize returns on the lowest reasonable capital base. This ensures minimized dilution for founders and a collaborative path toward achieving market impact and sustainable growth.
Easton Capital has 18 tracked investments across 12 companies. The latest tracked deal is $15.0M Series C in Claret Medical in October 2017.